We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Time Spent Reporting Is Under Review for Unapproved Drug Exports
Time Spent Reporting Is Under Review for Unapproved Drug Exports
January 16, 2009
The U.S. Food and Drug Administration (FDA) is seeking industry comment on data collection for companies seeking to export medical products.
To View This Article:
Login
Subscribe To International Pharmaceutical Regulatory Monitor